[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Vaccine Market - Global Outlook and Forecast 2021-2027

March 2021 | 110 pages | ID: V3CD07EBCF34EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Vaccine in Global, including the following market information:

Global Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Vaccine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Vaccine Market Segment Percentages, By Type, 2020 (%)
  • Varicella Vaccine
  • Influenza Vaccine
  • Polio Vaccine
  • Hepatitis A Vaccine
  • Rabies Vaccine
  • BCG Vaccine
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Others
China Vaccine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Vaccine Market Segment Percentages, By Application, 2020 (%)
  • For Adult
  • For Child
Global Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Vaccine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Vaccine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • AstraZeneca
  • BioNTech
  • Boehringer-Ingelheim
  • CCBIO
  • CSL
  • CureVac
  • Elanco
  • GSK
  • Hulan Bio
  • Indian Immunologicals
  • Merck
  • Minhai Biotechnology
  • Mitsubishi Tanabe Pharma
  • Moderna Therapeutics
  • Mylan
  • Plumbline Life Sciences
  • Sanofi
  • Translate Bio
  • Walvax Biotechnology
  • Wuhan Institute of Biological Products
  • Zoties
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VACCINE OVERALL MARKET SIZE

2.1 Global Vaccine Market Size: 2021 VS 2027
2.2 Global Vaccine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vaccine Players in Global Market
3.2 Top Global Vaccine Companies Ranked by Revenue
3.3 Global Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Vaccine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Vaccine Market Size Markets, 2021 & 2027
  4.1.2 Varicella Vaccine
  4.1.3 Influenza Vaccine
  4.1.4 Polio Vaccine
  4.1.5 Hepatitis A Vaccine
  4.1.6 Rabies Vaccine
  4.1.7 BCG Vaccine
  4.1.8 Hepatitis B
  4.1.9 Pertussis, Diphtheria, Tetanus
  4.1.10 Pneumococcal
  4.2.11 Others
4.2 By Type - Global Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Vaccine Revenue, 2016-2021
  4.2.2 By Type - Global Vaccine Revenue, 2022-2027
  4.2.3 By Type - Global Vaccine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaccine Market Size, 2021 & 2027
  5.1.2 For Adult
  5.1.3 For Child
5.2 By Application - Global Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Vaccine Revenue, 2016-2021
  5.2.2 By Application - Global Vaccine Revenue, 2022-2027
  5.2.3 By Application - Global Vaccine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Vaccine Revenue, 2016-2021
  6.2.2 By Region - Global Vaccine Revenue, 2022-2027
  6.2.3 By Region - Global Vaccine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Vaccine Revenue, 2016-2027
  6.3.2 US Vaccine Market Size, 2016-2027
  6.3.3 Canada Vaccine Market Size, 2016-2027
  6.3.4 Mexico Vaccine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Vaccine Revenue, 2016-2027
  6.4.2 Germany Vaccine Market Size, 2016-2027
  6.4.3 France Vaccine Market Size, 2016-2027
  6.4.4 U.K. Vaccine Market Size, 2016-2027
  6.4.5 Italy Vaccine Market Size, 2016-2027
  6.4.6 Russia Vaccine Market Size, 2016-2027
  6.4.7 Nordic Countries Vaccine Market Size, 2016-2027
  6.4.8 Benelux Vaccine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Vaccine Revenue, 2016-2027
  6.5.2 China Vaccine Market Size, 2016-2027
  6.5.3 Japan Vaccine Market Size, 2016-2027
  6.5.4 South Korea Vaccine Market Size, 2016-2027
  6.5.5 Southeast Asia Vaccine Market Size, 2016-2027
  6.5.6 India Vaccine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Vaccine Revenue, 2016-2027
  6.6.2 Brazil Vaccine Market Size, 2016-2027
  6.6.3 Argentina Vaccine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vaccine Revenue, 2016-2027
  6.7.2 Turkey Vaccine Market Size, 2016-2027
  6.7.3 Israel Vaccine Market Size, 2016-2027
  6.7.4 Saudi Arabia Vaccine Market Size, 2016-2027
  6.7.5 UAE Vaccine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Vaccine Major Product Offerings
  7.1.4 AstraZeneca Vaccine Revenue in Global (2016-2021)
  7.1.5 AstraZeneca Key News
7.2 BioNTech
  7.2.1 BioNTech Corporate Summary
  7.2.2 BioNTech Business Overview
  7.2.3 BioNTech Vaccine Major Product Offerings
  7.2.4 BioNTech Vaccine Revenue in Global (2016-2021)
  7.2.5 BioNTech Key News
7.3 Boehringer-Ingelheim
  7.3.1 Boehringer-Ingelheim Corporate Summary
  7.3.2 Boehringer-Ingelheim Business Overview
  7.3.3 Boehringer-Ingelheim Vaccine Major Product Offerings
  7.3.4 Boehringer-Ingelheim Vaccine Revenue in Global (2016-2021)
  7.3.5 Boehringer-Ingelheim Key News
7.4 CCBIO
  7.4.1 CCBIO Corporate Summary
  7.4.2 CCBIO Business Overview
  7.4.3 CCBIO Vaccine Major Product Offerings
  7.4.4 CCBIO Vaccine Revenue in Global (2016-2021)
  7.4.5 CCBIO Key News
7.5 CSL
  7.5.1 CSL Corporate Summary
  7.5.2 CSL Business Overview
  7.5.3 CSL Vaccine Major Product Offerings
  7.5.4 CSL Vaccine Revenue in Global (2016-2021)
  7.5.5 CSL Key News
7.6 CureVac
  7.6.1 CureVac Corporate Summary
  7.6.2 CureVac Business Overview
  7.6.3 CureVac Vaccine Major Product Offerings
  7.6.4 CureVac Vaccine Revenue in Global (2016-2021)
  7.6.5 CureVac Key News
7.7 Elanco
  7.7.1 Elanco Corporate Summary
  7.7.2 Elanco Business Overview
  7.7.3 Elanco Vaccine Major Product Offerings
  7.4.4 Elanco Vaccine Revenue in Global (2016-2021)
  7.7.5 Elanco Key News
7.8 GSK
  7.8.1 GSK Corporate Summary
  7.8.2 GSK Business Overview
  7.8.3 GSK Vaccine Major Product Offerings
  7.8.4 GSK Vaccine Revenue in Global (2016-2021)
  7.8.5 GSK Key News
7.9 Hulan Bio
  7.9.1 Hulan Bio Corporate Summary
  7.9.2 Hulan Bio Business Overview
  7.9.3 Hulan Bio Vaccine Major Product Offerings
  7.9.4 Hulan Bio Vaccine Revenue in Global (2016-2021)
  7.9.5 Hulan Bio Key News
7.10 Indian Immunologicals
  7.10.1 Indian Immunologicals Corporate Summary
  7.10.2 Indian Immunologicals Business Overview
  7.10.3 Indian Immunologicals Vaccine Major Product Offerings
  7.10.4 Indian Immunologicals Vaccine Revenue in Global (2016-2021)
  7.10.5 Indian Immunologicals Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Vaccine Major Product Offerings
  7.11.4 Merck Vaccine Revenue in Global (2016-2021)
  7.11.5 Merck Key News
7.12 Minhai Biotechnology
  7.12.1 Minhai Biotechnology Corporate Summary
  7.12.2 Minhai Biotechnology Business Overview
  7.12.3 Minhai Biotechnology Vaccine Major Product Offerings
  7.12.4 Minhai Biotechnology Vaccine Revenue in Global (2016-2021)
  7.12.5 Minhai Biotechnology Key News
7.13 Mitsubishi Tanabe Pharma
  7.13.1 Mitsubishi Tanabe Pharma Corporate Summary
  7.13.2 Mitsubishi Tanabe Pharma Business Overview
  7.13.3 Mitsubishi Tanabe Pharma Vaccine Major Product Offerings
  7.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue in Global (2016-2021)
  7.13.5 Mitsubishi Tanabe Pharma Key News
7.14 Moderna Therapeutics
  7.14.1 Moderna Therapeutics Corporate Summary
  7.14.2 Moderna Therapeutics Business Overview
  7.14.3 Moderna Therapeutics Vaccine Major Product Offerings
  7.14.4 Moderna Therapeutics Vaccine Revenue in Global (2016-2021)
  7.14.5 Moderna Therapeutics Key News
7.15 Mylan
  7.15.1 Mylan Corporate Summary
  7.15.2 Mylan Business Overview
  7.15.3 Mylan Vaccine Major Product Offerings
  7.15.4 Mylan Vaccine Revenue in Global (2016-2021)
  7.15.5 Mylan Key News
7.16 Plumbline Life Sciences
  7.16.1 Plumbline Life Sciences Corporate Summary
  7.16.2 Plumbline Life Sciences Business Overview
  7.16.3 Plumbline Life Sciences Vaccine Major Product Offerings
  7.16.4 Plumbline Life Sciences Vaccine Revenue in Global (2016-2021)
  7.16.5 Plumbline Life Sciences Key News
7.17 Sanofi
  7.17.1 Sanofi Corporate Summary
  7.17.2 Sanofi Business Overview
  7.17.3 Sanofi Vaccine Major Product Offerings
  7.17.4 Sanofi Vaccine Revenue in Global (2016-2021)
  7.17.5 Sanofi Key News
7.18 Translate Bio
  7.18.1 Translate Bio Corporate Summary
  7.18.2 Translate Bio Business Overview
  7.18.3 Translate Bio Vaccine Major Product Offerings
  7.18.4 Translate Bio Vaccine Revenue in Global (2016-2021)
  7.18.5 Translate Bio Key News
7.19 Walvax Biotechnology
  7.19.1 Walvax Biotechnology Corporate Summary
  7.19.2 Walvax Biotechnology Business Overview
  7.19.3 Walvax Biotechnology Vaccine Major Product Offerings
  7.19.4 Walvax Biotechnology Vaccine Revenue in Global (2016-2021)
  7.19.5 Walvax Biotechnology Key News
7.20 Wuhan Institute of Biological Products
  7.20.1 Wuhan Institute of Biological Products Corporate Summary
  7.20.2 Wuhan Institute of Biological Products Business Overview
  7.20.3 Wuhan Institute of Biological Products Vaccine Major Product Offerings
  7.20.4 Wuhan Institute of Biological Products Vaccine Revenue in Global (2016-2021)
  7.20.5 Wuhan Institute of Biological Products Key News
7.21 Zoties
  7.21.1 Zoties Corporate Summary
  7.21.2 Zoties Business Overview
  7.21.3 Zoties Vaccine Major Product Offerings
  7.21.4 Zoties Vaccine Revenue in Global (2016-2021)
  7.21.5 Zoties Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Vaccine Market Opportunities & Trends in Global Market
Table 2. Vaccine Market Drivers in Global Market
Table 3. Vaccine Market Restraints in Global Market
Table 4. Key Players of Vaccine in Global Market
Table 5. Top Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Vaccine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Vaccine Product Type
Table 9. List of Global Tier 1 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Vaccine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Vaccine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Vaccine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Vaccine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Vaccine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Vaccine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Vaccine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Vaccine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Vaccine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Vaccine Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Vaccine Product Offerings
Table 32. AstraZeneca Vaccine Revenue (US$, Mn), (2016-2021)
Table 33. BioNTech Corporate Summary
Table 34. BioNTech Vaccine Product Offerings
Table 35. BioNTech Vaccine Revenue (US$, Mn), (2016-2021)
Table 36. Boehringer-Ingelheim Corporate Summary
Table 37. Boehringer-Ingelheim Vaccine Product Offerings
Table 38. Boehringer-Ingelheim Vaccine Revenue (US$, Mn), (2016-2021)
Table 39. CCBIO Corporate Summary
Table 40. CCBIO Vaccine Product Offerings
Table 41. CCBIO Vaccine Revenue (US$, Mn), (2016-2021)
Table 42. CSL Corporate Summary
Table 43. CSL Vaccine Product Offerings
Table 44. CSL Vaccine Revenue (US$, Mn), (2016-2021)
Table 45. CureVac Corporate Summary
Table 46. CureVac Vaccine Product Offerings
Table 47. CureVac Vaccine Revenue (US$, Mn), (2016-2021)
Table 48. Elanco Corporate Summary
Table 49. Elanco Vaccine Product Offerings
Table 50. Elanco Vaccine Revenue (US$, Mn), (2016-2021)
Table 51. GSK Corporate Summary
Table 52. GSK Vaccine Product Offerings
Table 53. GSK Vaccine Revenue (US$, Mn), (2016-2021)
Table 54. Hulan Bio Corporate Summary
Table 55. Hulan Bio Vaccine Product Offerings
Table 56. Hulan Bio Vaccine Revenue (US$, Mn), (2016-2021)
Table 57. Indian Immunologicals Corporate Summary
Table 58. Indian Immunologicals Vaccine Product Offerings
Table 59. Indian Immunologicals Vaccine Revenue (US$, Mn), (2016-2021)
Table 60. Merck Corporate Summary
Table 61. Merck Vaccine Product Offerings
Table 62. Merck Vaccine Revenue (US$, Mn), (2016-2021)
Table 63. Minhai Biotechnology Corporate Summary
Table 64. Minhai Biotechnology Vaccine Product Offerings
Table 65. Minhai Biotechnology Vaccine Revenue (US$, Mn), (2016-2021)
Table 66. Mitsubishi Tanabe Pharma Corporate Summary
Table 67. Mitsubishi Tanabe Pharma Vaccine Product Offerings
Table 68. Mitsubishi Tanabe Pharma Vaccine Revenue (US$, Mn), (2016-2021)
Table 69. Moderna Therapeutics Corporate Summary
Table 70. Moderna Therapeutics Vaccine Product Offerings
Table 71. Moderna Therapeutics Vaccine Revenue (US$, Mn), (2016-2021)
Table 72. Mylan Corporate Summary
Table 73. Mylan Vaccine Product Offerings
Table 74. Mylan Vaccine Revenue (US$, Mn), (2016-2021)
Table 75. Plumbline Life Sciences Corporate Summary
Table 76. Plumbline Life Sciences Vaccine Product Offerings
Table 77. Plumbline Life Sciences Vaccine Revenue (US$, Mn), (2016-2021)
Table 78. Sanofi Corporate Summary
Table 79. Sanofi Vaccine Product Offerings
Table 80. Sanofi Vaccine Revenue (US$, Mn), (2016-2021)
Table 81. Translate Bio Corporate Summary
Table 82. Translate Bio Vaccine Product Offerings
Table 83. Translate Bio Vaccine Revenue (US$, Mn), (2016-2021)
Table 84. Walvax Biotechnology Corporate Summary
Table 85. Walvax Biotechnology Vaccine Product Offerings
Table 86. Walvax Biotechnology Vaccine Revenue (US$, Mn), (2016-2021)
Table 87. Wuhan Institute of Biological Products Corporate Summary
Table 88. Wuhan Institute of Biological Products Vaccine Product Offerings
Table 89. Wuhan Institute of Biological Products Vaccine Revenue (US$, Mn), (2016-2021)
Table 90. Zoties Corporate Summary
Table 91. Zoties Vaccine Product Offerings
Table 92. Zoties Vaccine Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Vaccine Segment by Type
Figure 2. Vaccine Segment by Application
Figure 3. Global Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaccine Revenue in 2020
Figure 8. By Type - Global Vaccine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Vaccine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Vaccine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Vaccine Revenue Market Share, 2016-2027
Figure 12. US Vaccine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Vaccine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Vaccine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Vaccine Revenue Market Share, 2016-2027
Figure 16. Germany Vaccine Revenue, (US$, Mn), 2016-2027
Figure 17. France Vaccine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Vaccine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Vaccine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Vaccine Revenue Market Share, 2016-2027
Figure 24. China Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. India Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Vaccine Revenue Market Share, 2016-2027
Figure 30. Brazil Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Vaccine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Vaccine Revenue Market Share, 2016-2027
Figure 33. Turkey Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BioNTech Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Boehringer-Ingelheim Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. CCBIO Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. CSL Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. CureVac Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Elanco Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. GSK Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Hulan Bio Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Indian Immunologicals Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Merck Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Minhai Biotechnology Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Mitsubishi Tanabe Pharma Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Moderna Therapeutics Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Mylan Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Plumbline Life Sciences Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Sanofi Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Translate Bio Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Walvax Biotechnology Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Wuhan Institute of Biological Products Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications